Pacira BioSciences, Inc. (PCRX) — Capital Reinvestment Ratio
Pacira BioSciences, Inc. (PCRX) has a Capital Reinvestment Ratio of 0.02x as of June 2026, meaning it reinvests 0% of its operating cash flow ($57.46 Million) in capital expenditures ($1.34 Million). Check Pacira BioSciences, Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pacira BioSciences, Inc. Capital Reinvestment Ratio (2014–2025)
This chart tracks Pacira BioSciences, Inc.'s Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see PCRX operating cash flow.
Annual Capital Reinvestment Ratio for Pacira BioSciences, Inc. (2014–2025)
Year-by-year Capital Reinvestment Ratio for Pacira BioSciences, Inc. from 2014 to 2025. See how much free cash does Pacira BioSciences, Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $151.99 Million | $15.33 Million | ▲ +79.6% |
| 2024 | 0.06x | $189.39 Million | $10.64 Million | ▼ -42.7% |
| 2023 | 0.10x | $154.65 Million | $15.16 Million | ▼ -52.6% |
| 2022 | 0.21x | $145.27 Million | $30.08 Million | ▼ -43.3% |
| 2021 | 0.36x | $125.72 Million | $45.87 Million | ▼ -25.7% |
| 2020 | 0.49x | $77.03 Million | $37.80 Million | ▲ +240.6% |
| 2019 | 0.14x | $70.52 Million | $10.16 Million | ▼ -51.5% |
| 2018 | 0.30x | $48.87 Million | $14.51 Million | ▼ -72.6% |
| 2017 | 1.08x | $17.79 Million | $19.27 Million | ▲ +46.7% |
| 2016 | 0.74x | $33.45 Million | $24.71 Million | ▼ -48.1% |
| 2015 | 1.42x | $29.00 Million | $41.27 Million | ▲ +65.6% |
| 2014 | 0.86x | $25.47 Million | $21.89 Million | — |